Browse > Article
http://dx.doi.org/10.7730/JSCM.2015.27.1.125

Exploratory Study on the Pre-and Post-Prandial Subjective Appetite and Plasma Gut Hormone Levels in Spleen Qi Deficiency (SQD) Syndrome  

Oh, Hye-Won (Dept. of Sasang Constitutional Medicine, Kyung Hee University Korean Hospital)
Lee, Ji-Won (Dept. of Sasang Constitutional Medicine, Kyung Hee University Korean Hospital)
Kim, Je-Sin (Dept. of Sasang Constitutional Medicine, Kyung Hee University Korean Hospital)
Lee, Jun-Hee (Dept. of Sasang Constitutional Medicine, College of Korean Medicine, Kyung Hee University)
Publication Information
Journal of Sasang Constitutional Medicine / v.27, no.1, 2015 , pp. 125-137 More about this Journal
Abstract
Objectives The aim of this study was to investigate clinical factors of SQD syndrome by tracking plasma gut hormone (active ghrelin, active Glucagon-like peptide-1(GLP-1), pancreatic polypeptide(PP), total peptide YY(PYY)) profiling of pre-post prandial standard meal between SQD group and normal group. Methods A total of 24 adult participants were consecutively recruited on April 2014. They were diagnosed as either by SQD syndrome or normal by Spleen Qi Deficiency Questionnaire (SQDQ). On the experimental day, blood samplings of 2 ml were repeatedly collected at 6 points from 2 groups for measuring plasma levels of gut hormones. At every point, subjective appetite sensations were self-registered. Results & Conclusions 1. There were significantly lower subjective 'Appetite' (p=0.012) and higher 'Satiety' (p=0.012) in SQD group. At each time point, subjective 'Appetite' was significantly lower at 60 min after breakfast (p=0.034) and 'Satiety' were significantly higher at 15 min (p=0.020) and 120 min (p=0.044) after breakfast in SQD group. 2. There were no significant differences in plasma levels of gut hormones (active ghrelin, active GLP-1, PP, total PYY) between SQD and normal group. Also at each time point, there were no significant differences of plasma levels of gut hormones between SQD and normal group. 3. Changes in plasma levels of gut hormones compared to baseline were not significantly different at each time point between SQD and normal group. Plasma PYY levels compared to baseline increased in SQD group following 15 min and 30 min after breakfast but decreased in normal group. 4. Further investigation is needed to construct gut hormone profiling and in this perspective, we can approach evaluation tool on variable appetite in Traditional Korean Medicine (TKM) syndrome in the future.
Keywords
Spleen Qi Deficiency; Spleen Qi Deficiency Questionnaire; Gut Hormone; Appetite;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Jeong HS, Ha KT, Shin SW, Lee KG. Study on the Endogenous Dampness Caused by Gi Deficiency of the Spleen and Sagunja-tang. Korean J. Oriental Physiology & Pathology. 2010;24(6):903-906. (Korean)
2 Teaching material compilation committee of oriental pathology. Oriental pathology. 2nd edition. Seoul: Hanuimunhwasa. 2008:411-414.
3 Neary MT, Batterham RL. Gut hormones: implications for the treatment of obesity. Pharmacol Ther. 2009;124(1):44-56.   DOI
4 Lee JH, Lee JW, Shin HS, Kim KS, Lee EJ, Koh BH, et al. Suggestion of new possibilities in approaching individual variability in appetite through constitutional typology: a pilot study. BMC Complementary and Alternative Medicine. 2012;12:122.   DOI
5 Oh HW, Lee JW, Kim JS, Song EY, Shin SW, Han GJ, et al. Study on the Development of a Standard Instrument of Diagnosis and Assessment for Spleen Qi Deficiency Pattern. J Korean med. 2014;35(1):157-170. (Korean)   DOI
6 Lee JH. The annual report on the Traditional Korean Medicine R&D Project, Ministry of Health & Welfare (The Modeling of Gut Hormone Profiling of Spleen Qi Deficiency Pattern and the Development of Efficacy Evaluation Technique of Related Herbal Medicine (HI13C0623)). 2014:31-36. (Korean)
7 Bailly N, Maitre I, Amanda M, Herve C, Alaphilippe D. The Dutch Eating Behaviour Questionnaire (DEBQ). Assessment of eating behaviour in an aging French population. Appetite. 2012;59(3):853-858.   DOI
8 Wren AM, Bloom SR. Gut hormones and appetite control. Gastroenterology. 2007;132(6):2116-2130.   DOI
9 Rachel CT, Tricia MT, Steve RB. The future role of gut hormones in the treatment of obesity. Ther Adv Chronic Dis. 2014;5(1):4-14.   DOI